Globe News Wire
25 Sept 2026, 09:31 UTC · 1h ago
Verdict
Headline leans bullish. Three claims average +0.30.
Score confirms the headline.
Leans bullish
From its wording — no explicit rating
+0.30moderately bullish
What the story claims
3 claims · scored −1 bearish … +1 bullish · 3 new · 0 priced in
The global connected drug delivery devices market is projected to grow from USD 5.3 billion in 2026 to USD 12.7 billion by 2035.
NewReport added to ResearchAndMarkets.com on Sept. 25, 2026
So whatThis represents a 139% total increase over the 9-year horizon, suggesting significant upside for hardware providers in the biologics space.
More positive than 78% of claims this week
Continue reading
5 related stories
More positive than 64% of claims this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
The connected drug delivery devices market is expected to exhibit a compound annual growth rate (CAGR) of 10.2% through 2035.
NewReport added to ResearchAndMarkets.com on Sept. 25, 2026
So whatConsistent double-digit growth through 2035 supports higher valuation multiples for pure-play digital health delivery firms.
More positive than 64% of claims this week
The inhalational segment is expected to record stronger growth through 2035 compared to the currently dominant parenteral segment.
NewReport added to ResearchAndMarkets.com on Sept. 25, 2026
So whatA shift toward respiratory growth suggests increased R&D spending on smart inhalers for asthma and COPD in coming fiscal years.
More positive than 52% of claims this week
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Reuters
2h ago
